Status: awaiting_review. Rule: atlas-profile-2.0.
9 linked publications; not a count of independent studies.
Missing appraisal does not mean no evidence exists. Inspect the full profile and source relationships in the interactive Atlas.
Historical grade: WEAK (retained from 22 September 2026; not a completed profile 2.0 assessment).
BraTS drove robust, near-expert automated tumor segmentation (nnU-Net etc.); enables volumetrics at scale
Marginal Dice gains are clinically meaningless; benchmark curation (skull-strip, co-registration, expert consensus labels) does not reflect messy clinical data; volumetric RANO not yet standard
Field effort concentrated on a solved-ish task while measurement standardization for trials lags
This is an educational research resource from Resonant Labs, not clinical advice. Atlas assessments are heuristic, not probabilities or formal GRADE ratings. Findings are summarized from the literature and may change as the field evolves.